• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥美拉唑、阿莫西林和克拉霉素三联疗法后的胃液、胃组织及血液抗生素浓度

Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy.

作者信息

Nakamura Masahiko, Spiller Robin C, Barrett David A, Wibawa Judata I D, Kumagai Naoki, Tsuchimoto Kanji, Tanaka Takeshi

机构信息

Research Center for Clinical Pharmacology, Center for Basic Research, Kitasato Institute, Tokyo, Japan.

出版信息

Helicobacter. 2003 Aug;8(4):294-9. doi: 10.1046/j.1523-5378.2003.00156.x.

DOI:10.1046/j.1523-5378.2003.00156.x
PMID:12950601
Abstract

BACKGROUND

Amoxicillin and clarithromycin are key antibiotics in proton pump inhibitor-based Helicobacter pylori eradication therapies.

AIMS

To study gastric mucus and tissue concentrations and collect basic data about optimal antibacterial doses.

METHODS

Plasma, gastric mucosa and gastric juice antibiotic concentrations were measured following either low- or high-dose amoxicillin (750 or 1000 mg b.i.d.) and clarithromycin (400 or 500 mg b.i.d.) given in combination with omeprazole 20 mg bid to 12 male volunteers in an open crossover design. Gastric juice and mucosal biopsy collection was performed either 2 (n=6) or 6 hours (n=6) after dosing.

RESULTS

Amoxicillin concentrations 2 hours after high dosage were gastric juice > gastric body > antral mucosa > plasma. At 6 hours, plasma and gastric juice concentrations were still above the MIC for amoxicillin-susceptible bacteria but no antibiotic was detectable in mucosa samples. Clarithromycin concentrations after high dosage were gastric juice > mucosa > serum; all above the MIC for clarithromycin-susceptible bacteria at both 2 and 6 hours.

CONCLUSIONS

Both dosage regimens provided effective antibiotic concentrations in gastric juice at 2 hours. After dosing, both antibiotics demonstrated high gastric tissue concentrations via local diffusion while clarithromycin also provided sustained delivery (6 hours) via gastric mucosa penetration.

摘要

背景

阿莫西林和克拉霉素是基于质子泵抑制剂的幽门螺杆菌根除疗法中的关键抗生素。

目的

研究胃黏液和组织中的浓度,并收集关于最佳抗菌剂量的基础数据。

方法

采用开放交叉设计,对12名男性志愿者给予低剂量或高剂量的阿莫西林(750或1000毫克,每日两次)和克拉霉素(400或500毫克,每日两次),并联合20毫克奥美拉唑,每日两次。给药后2小时(n = 6)或6小时(n = 6)进行胃液和黏膜活检采集。

结果

高剂量给药后2小时,阿莫西林浓度在胃液中 > 胃体 > 胃窦黏膜 > 血浆。6小时时,血浆和胃液浓度仍高于对阿莫西林敏感细菌的最低抑菌浓度,但在黏膜样本中未检测到抗生素。高剂量给药后克拉霉素浓度在胃液中 > 黏膜 > 血清;在2小时和6小时时均高于对克拉霉素敏感细菌的最低抑菌浓度。

结论

两种给药方案在2小时时均能在胃液中提供有效的抗生素浓度。给药后,两种抗生素均通过局部扩散在胃组织中呈现高浓度,而克拉霉素还通过胃黏膜渗透提供持续释放(6小时)。

相似文献

1
Gastric juice, gastric tissue and blood antibiotic concentrations following omeprazole, amoxicillin and clarithromycin triple therapy.奥美拉唑、阿莫西林和克拉霉素三联疗法后的胃液、胃组织及血液抗生素浓度
Helicobacter. 2003 Aug;8(4):294-9. doi: 10.1046/j.1523-5378.2003.00156.x.
2
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice.
Gastroenterology. 1996 Aug;111(2):358-67. doi: 10.1053/gast.1996.v111.pm8690200.
3
Pharmacokinetics of lansoprazole, amoxicillin and clarithromycin after simultaneous and single administration.兰索拉唑、阿莫西林和克拉霉素同时给药及单次给药后的药代动力学
J Antimicrob Chemother. 2002 Nov;50(5):699-706. doi: 10.1093/jac/dkf172.
4
Localization of [14C]amoxicillin in rat gastric tissue when administered with lansoprazole and clarithromycin.
J Antimicrob Chemother. 2001 Dec;48(6):923-6. doi: 10.1093/jac/48.6.923.
5
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy.
Gastroenterology. 1996 Aug;111(2):521-3. doi: 10.1053/gast.1996.v111.agast961110521.
6
Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.三联疗法与双重疗法根除幽门螺杆菌及预防溃疡复发的比较:一项关于兰索拉唑、克拉霉素和/或阿莫西林不同给药方案的随机、双盲、多中心研究。
Am J Gastroenterol. 1998 Apr;93(4):584-90. doi: 10.1111/j.1572-0241.1998.169_b.x.
7
Triple therapy with lansoprazole, clarithromycin, and amoxicillin for the cure of Helicobacter pylori infection: a short report.兰索拉唑、克拉霉素和阿莫西林三联疗法治疗幽门螺杆菌感染:一篇简短报告。
Helicobacter. 1996 Dec;1(4):238-42. doi: 10.1111/j.1523-5378.1996.tb00045.x.
8
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.幽门螺杆菌对克拉霉素的耐药性对奥美拉唑-阿莫西林-克拉霉素疗法的疗效有重大影响。
Pathol Biol (Paris). 2001 Sep;49(7):528-33. doi: 10.1016/s0369-8114(01)00209-7.
9
Transfer of clarithromycin to gastric juice is enhanced by omeprazole in Helicobacter pylori-infected individuals.
Scand J Gastroenterol. 2001 Dec;36(12):1248-53. doi: 10.1080/003655201317097074.
10
Efficacy and safety of Helicobacter pylori eradication therapy with omeprazole, amoxicillin and high- and low-dose clarithromycin in Japanese patients: a randomised, double-blind, multicentre study.奥美拉唑、阿莫西林联合高剂量及低剂量克拉霉素根除幽门螺杆菌治疗日本患者的疗效和安全性:一项随机、双盲、多中心研究
Clin Drug Investig. 2006;26(7):403-14. doi: 10.2165/00044011-200626070-00002.

引用本文的文献

1
Antibiotic Resistance of : Mechanisms and Clinical Implications.耐药性的抗生素 : 机制和临床意义。
J Korean Med Sci. 2024 Jan 29;39(4):e44. doi: 10.3346/jkms.2024.39.e44.
2
Dynamic Monitoring of Systemic Biomarkers with Gastric Sensors.胃传感器的系统生物标志物的动态监测。
Adv Sci (Weinh). 2021 Dec;8(24):e2102861. doi: 10.1002/advs.202102861. Epub 2021 Oct 28.
3
Helicobacter pylori infection and antibiotic resistance - from biology to clinical implications.幽门螺杆菌感染和抗生素耐药性 - 从生物学到临床意义。
Nat Rev Gastroenterol Hepatol. 2021 Sep;18(9):613-629. doi: 10.1038/s41575-021-00449-x. Epub 2021 May 17.
4
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in : A Literature Review.下一代测序技术在预测[具体内容]抗生素耐药性中的应用:文献综述
Antibiotics (Basel). 2021 Apr 14;10(4):437. doi: 10.3390/antibiotics10040437.
5
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.用于口服给药的纳米颗粒:设计、评估与最新进展
J Control Release. 2016 Oct 28;240:504-526. doi: 10.1016/j.jconrel.2016.06.016. Epub 2016 Jun 9.
6
Biofilm Formation by Helicobacter pylori and Its Involvement for Antibiotic Resistance.幽门螺杆菌生物膜的形成及其与抗生素耐药性的关系
Biomed Res Int. 2015;2015:914791. doi: 10.1155/2015/914791. Epub 2015 May 19.
7
Challenging the dogma: a randomized trial of standard vs. half-dose concomitant nonbismuth quadruple therapy for Helicobacter pylori infection.挑战教条:标准剂量与半剂量非铋四联疗法治疗幽门螺杆菌感染的随机试验。
United European Gastroenterol J. 2014 Jun;2(3):179-88. doi: 10.1177/2050640614530919.
8
Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.链霉蛋白酶增强低剂量抗生素根除幽门螺杆菌的疗效及药理机制
Antimicrob Agents Chemother. 2014 Jun;58(6):3348-53. doi: 10.1128/AAC.02319-13. Epub 2014 Mar 31.
9
Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.幽门螺杆菌生物膜形成对抗生素克拉霉素敏感性和耐药突变的影响。
PLoS One. 2013 Sep 6;8(9):e73301. doi: 10.1371/journal.pone.0073301. eCollection 2013.
10
Current recommendations for Helicobacter pylori therapies in a world of evolving resistance.当前在耐药性不断演变的世界中推荐的幽门螺杆菌治疗方法。
Gut Microbes. 2013 Nov-Dec;4(6):541-8. doi: 10.4161/gmic.25930. Epub 2013 Aug 5.